| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/21/1999 | US5955281 Screening cells for mutant forms of receptors or signal transduction proteins by transfecting cells with dna library, incubating cells with little or no agonist, measuring levels of marker |
| 09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955083 Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis |
| 09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
| 09/21/1999 | CA2174971C Neural axon outgrowth modulators |
| 09/21/1999 | CA2087703C Binary cryptocytotoxic method of hybrid seed production |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
| 09/16/1999 | WO1999046387A1 Biosynthetic genes for spinosyn insecticide production |
| 09/16/1999 | WO1999046382A1 Chondrosarcoma associated genes |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046380A2 Human membrane spanning proteins |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
| 09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
| 09/16/1999 | WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | WO1999046370A2 Expression of trehalose biosynthetic genes in plants |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999046366A1 Uses for humane non-autologous mesenchymal stem cells |
| 09/16/1999 | WO1999046365A1 Methods and compositions for the selective expansion of gamma/delta t-cells |
| 09/16/1999 | WO1999046364A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046287A1 Secreted proteins and polynucleotides encoding them |
| 09/16/1999 | WO1999046286A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 09/16/1999 | WO1999046285A2 Method of promoting production of living tissue equivalents |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 09/16/1999 | WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/16/1999 | WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11 |
| 09/16/1999 | WO1999045945A1 Improved radiation therapy methods |
| 09/16/1999 | WO1999045770A1 Skin equivalent and methods of forming and using same |
| 09/16/1999 | WO1999045767A1 Non-human transgenic mammal, method for producing same and its use |
| 09/16/1999 | WO1999038967A3 Recombinant proteins derived from hgf and msp |
| 09/16/1999 | WO1999037763A3 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 09/16/1999 | WO1999036511A3 Feline immunodeficiency virus gene therapy vectors |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999035106A3 Mammalian edg-7 receptor homologs |
| 09/16/1999 | WO1999033979A3 Bone marrow secreted proteins and polynucleotides |
| 09/16/1999 | WO1999029882A3 Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | WO1999009177B1 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 09/16/1999 | DE19815958C1 Non-human mammal - comprises glucocorticoid receptor with altered function in its induced state |
| 09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
| 09/16/1999 | DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents |
| 09/16/1999 | DE19811114A1 Preparation of multi-cellular three-dimensional aggregates of living blood vessel endothelial cells |
| 09/16/1999 | DE19810947A1 Removal of biological contaminants from biological products using anion-exchange membrane |
| 09/16/1999 | DE19810879A1 New chimeric polymerase with 5'-3'-polymerase activity, and optionally proofreading activity, used for polymerase chain reactions and sequencing |
| 09/16/1999 | CA2659664A1 Improved radiation therapy methods |
| 09/16/1999 | CA2363540A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
| 09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
| 09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
| 09/16/1999 | CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | CA2323076A1 Chondrosarcoma associated genes |
| 09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
| 09/16/1999 | CA2322771A1 Human membrane spanning proteins |
| 09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | CA2322732A1 Secreted proteins and polynucleotides encoding them |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322662A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2322449A1 Biosynthetic genes for spinosyn insecticide production |
| 09/16/1999 | CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases |
| 09/16/1999 | CA2320896A1 Expression of trehalose biosynthetic genes in plants |
| 09/16/1999 | CA2244235A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
| 09/15/1999 | EP0942066A2 Cell line of blood-brain barrier |
| 09/15/1999 | EP0941478A1 Assay method for peptide specific t-cells |
| 09/15/1999 | EP0941368A2 Method for detection of metastatic prostate cancer |
| 09/15/1999 | EP0941364A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 09/15/1999 | EP0941348A1 Enhanced transport with a plastid membrane transport protein |
| 09/15/1999 | EP0941347A2 Methods of producing a recombinant protein |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941344A1 HUMANIZED ANTI-CD11a ANTIBODIES |
| 09/15/1999 | EP0941343A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof |
| 09/15/1999 | EP0941342A1 Human squalene epoxidase |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941340A1 Transgenic plants having increased starch content |
| 09/15/1999 | EP0941339A1 Therapeutic gene |
| 09/15/1999 | EP0941337A1 Synthesis and purification of hepatitis c virus-like particles |
| 09/15/1999 | EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
| 09/15/1999 | EP0941332A2 Carrot antifreeze polypeptides |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
| 09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 09/15/1999 | EP0941324A1 Protein targeting to glycogen |
| 09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/15/1999 | EP0941317A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941310A1 Methods for the generation of primordial germ cells and transgenic animal species |
| 09/15/1999 | EP0941309A1 Cellular adjuvant |
| 09/15/1999 | EP0941307A1 Use of flexible plastic tanks in gene theraphy |
| 09/15/1999 | EP0941250A1 HUMAN BLUE-LIGHT PHOTORECEPTOR hCRY2 |
| 09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |